| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Published online before print May 31, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



From the Departments of Dermatology,* Gynaecology,
and Radiotherapy,
Martin Luther University Halle-Wittenberg, Halle, Germany; the Department of Radiotherapy,
University of Lübeck, Lübeck, Germany; the Institute of Pathology,¶ Medical University of Vienna, Vienna, Austria; and the Department of Dermatology,|| University of Heidelberg, Heidelberg, Germany
The time course of microvascular changes in the environment of irradiated tumors was studied in a standardized human protocol. Eighty skin biopsies from 40 patients with previously treated primary breast cancer were taken from irradiated skin and corresponding contralateral unirradiated control areas 2 to 8 weeks, 11 to 14 months, or 17+ months after radiotherapy (skin equivalent dose 30 to 40 Gy). Twenty-two biopsies of 11 melanoma patients who had undergone lymph node dissection were used for unirradiated control. We found an increase of total podoplanin+ lymphatic microvessel density resulting mainly from a duplication of the density of smallest lymphatic vessels (diameter <10 µm) in the samples taken 1 year after radiation. Our findings implicate radiogenic lymphangiogenesis during the 1st year after therapy. The numbers of CD68+ and vascular endothelial growth factor-C+ cells were highly elevated in irradiated skin in the samples taken 2 to 8 weeks after radiotherapy. Thus, our results indicate that vascular endothelial growth factor-C expression by invading macrophages could be a pathogenetic route of induction of radiogenic lymphangiogenesis.
This article has been cited by other articles:
![]() |
A. Holmqvist, J. Gao, G. Adell, J. Carstensen, and X.-F. Sun The location of lymphangiogenesis is an independent prognostic factor in rectal cancers with or without preoperative radiotherapy Ann. Onc., November 4, 2009; (2009) mdp486v1. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |